International economy of knowledgment and poverty: exclusion of development countries of the global drug market
DOI:
https://doi.org/10.11606/issn.2316-9044.v12i1p135-188Keywords:
ADPIC, Drugs, Intellectual Property, International Cooperation, Right to HealthAbstract
As international economic relations, health field follows the steps of the globalization. People talks, at the same time, about a global health economy and the internationalization of health risks. However, the developed countries and those who are in development are not in the same level to fight against diseases. There is a "health break" for many years symbolized by AIDS epidemic in poor countries. While scientific progress provides answers to several diseases, most of the inhabitants of the "South " has no regular access to medicines. At the heart of public health policies, the drug is becoming a commodity in a global economy focused on the exploration of knowledge, particularly the pharmaceutical innovation. The lack of access to treatment can be analyzed as a result of the exclusion of developing countries facing the pharmaceutical market, caused by socioeconomic status, by the structure of the market and by WTO's intellectual property rules.Downloads
Download data is not yet available.
Downloads
Published
2011-06-01
Issue
Section
Argument
License
The Revista de Direito Sanitário/ Journal of Health Law adopts the conditions of the Creative Commons Attribution 4.0 Internacional. This license allows to share - "copy and redistribute the material in any medium or format for any purpose, even commercially" and adapt - "remix, transform, and build upon the material for any purpose, even commercially." Details at: https://creativecommons.org/licenses/by/4.0/deed.en
How to Cite
Bréger, T. (2011). International economy of knowledgment and poverty: exclusion of development countries of the global drug market. Journal of Health Law, 12(1), 135-188. https://doi.org/10.11606/issn.2316-9044.v12i1p135-188